Ordinary Index Rebalancing in the Medical Care Growth Index | August 2021

In the ordinary rebalance the following composition will be implemented effective open 05.08.2021:

ADVERUM BIOTECHNOLOGIES INC
ANTARES PHARMA INC
ARCUS BIOSCIENCES INC
AXONICS INC
AYTU BIOPHARMA INC
BIOCEPT INC
BIODELIVERY SCIENCES INTERNATIONAL INC
BIOHAVEN PHARMACEUTICAL HOLD
CATALENT INC
CO-DIAGNOSTICS INC
DECIPHERA PHARMACEUTICALS INC
DENALI THERAPEUTICS INC
DICERNA PHARMACEUTICALS INC
DYNAVAX TECHNOLOGIES CORP
ETON PHARMACEUTICALS INC
FATE THERAPEUTICS INC
FULCRUM THERAPEUTICS INC
FULGENT GENETICS INC
GLOBAL BLOOD THERAPEUTICS IN
GRITSTONE BIO INC
HALOZYME THERAPEUTICS INC
HESKA CORP
HOLOGIC INC
HOMOLOGY MEDICINES INC
INARI MEDICAL INC
INCYTE CORP
INOVIO PHARMACEUTICALS INC
INTRA-CELLULAR THERAPIES INC
JOINT CORP/THE
KADMON HOLDINGS INC
KINDRED BIOSCIENCES INC
LA JOLLA PHARMACEUTICAL CO
LIGAND PHARMACEUTICALS INC
MATINAS BIOPHARMA HLDGS INC
MEI PHARMA INC
MERIDIAN BIOSCIENCE INC
MIRATI THERAPEUTICS INC
MODERNA INC
OCULAR THERAPEUTIX INC
ONCOCYTE CORP
ORGANOGENESIS HOLDINGS INC
PARATEK PHARMACEUTICALS INC
PERKINELMER INC
PROTAGONIST THERAPEUTICS INC
QUIDEL CORP
RADIUS HEALTH INC
REPLIGEN CORP
REVANCE THERAPEUTICS INC
SAGE THERAPEUTICS INC
SCYNEXIS INC
SELECTA BIOSCIENCES INC
SHOCKWAVE MEDICAL INC
SYROS PHARMACEUTICALS INC
TG THERAPEUTICS INC
TRANSLATE BIO INC
UROGEN PHARMA LTD
VACCINEX INC
VIR BIOTECHNOLOGY INC
XERIS PHARMACEUTICALS INC
ZOGENIX INC
ZYNEX INC